Logo image of IPX

IPERIONX LTD - ADR (IPX) Stock Fundamental Analysis

NASDAQ:IPX - Nasdaq - US44916E1001 - ADR - Currency: USD

24.19  +0.98 (+4.22%)

Fundamental Rating

3

Overall IPX gets a fundamental rating of 3 out of 10. We evaluated IPX against 153 industry peers in the Metals & Mining industry. While IPX seems to be doing ok healthwise, there are quite some concerns on its profitability. IPX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year IPX has reported negative net income.
IPX had a negative operating cash flow in the past year.
IPX had negative earnings in each of the past 5 years.
In the past 5 years IPX always reported negative operating cash flow.
IPX Yearly Net Income VS EBIT VS OCF VS FCFIPX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

The Return On Assets of IPX (-18.86%) is worse than 76.47% of its industry peers.
IPX's Return On Equity of -20.70% is on the low side compared to the rest of the industry. IPX is outperformed by 71.24% of its industry peers.
Industry RankSector Rank
ROA -18.86%
ROE -20.7%
ROIC N/A
ROA(3y)-111.03%
ROA(5y)-168.25%
ROE(3y)-139.15%
ROE(5y)-240.98%
ROIC(3y)N/A
ROIC(5y)N/A
IPX Yearly ROA, ROE, ROICIPX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for IPX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IPX Yearly Profit, Operating, Gross MarginsIPX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 -50K -100K -150K -200K -250K

More info and screens

6

2. Health

2.1 Basic Checks

IPX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for IPX has been increased compared to 1 year ago.
Compared to 5 years ago, IPX has more shares outstanding
The debt/assets ratio for IPX has been reduced compared to a year ago.
IPX Yearly Shares OutstandingIPX Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
IPX Yearly Total Debt VS Total AssetsIPX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

IPX has an Altman-Z score of 38.76. This indicates that IPX is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 38.76, IPX belongs to the top of the industry, outperforming 89.54% of the companies in the same industry.
A Debt/Equity ratio of 0.03 indicates that IPX is not too dependend on debt financing.
IPX has a better Debt to Equity ratio (0.03) than 71.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 38.76
ROIC/WACCN/A
WACC9.99%
IPX Yearly LT Debt VS Equity VS FCFIPX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

IPX has a Current Ratio of 11.80. This indicates that IPX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 11.80, IPX belongs to the best of the industry, outperforming 92.16% of the companies in the same industry.
A Quick Ratio of 11.80 indicates that IPX has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 11.80, IPX belongs to the best of the industry, outperforming 92.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 11.8
Quick Ratio 11.8
IPX Yearly Current Assets VS Current LiabilitesIPX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

4

3. Growth

3.1 Past

IPX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.37%.
IPX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.41%.
The Revenue has been growing by 78.65% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)3.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
Revenue 1Y (TTM)10.41%
Revenue growth 3Y374.83%
Revenue growth 5Y78.65%
Sales Q2Q%1998.62%

3.2 Future

IPX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 64.54% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y17.65%
EPS Next 2Y20.19%
EPS Next 3Y66.8%
EPS Next 5Y64.54%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IPX Yearly Revenue VS EstimatesIPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
IPX Yearly EPS VS EstimatesIPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 0 1 2 3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

IPX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year IPX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IPX Price Earnings VS Forward Price EarningsIPX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IPX Per share dataIPX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

IPX's earnings are expected to grow with 66.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.19%
EPS Next 3Y66.8%

More info and screens

0

5. Dividend

5.1 Amount

IPX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IPERIONX LTD - ADR

NASDAQ:IPX (5/30/2025, 8:05:35 PM)

24.19

+0.98 (+4.22%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)03-12 2025-03-12
Earnings (Next)09-25 2025-09-25
Inst Owners34.31%
Inst Owner Change-28.18%
Ins Owners13.4%
Ins Owner ChangeN/A
Market Cap708.05M
Analysts80
Price Target23.82 (-1.53%)
Short Float %0.68%
Short Ratio2
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)16.49%
PT rev (3m)-7.62%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-4.15%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-23.21%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1296.79
P/FCF N/A
P/OCF N/A
P/B 6.71
P/tB 7.75
EV/EBITDA N/A
EPS(TTM)-0.93
EYN/A
EPS(NY)-0.4
Fwd EYN/A
FCF(TTM)-1.25
FCFYN/A
OCF(TTM)-0.76
OCFYN/A
SpS0.02
BVpS3.61
TBVpS3.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.86%
ROE -20.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-111.03%
ROA(5y)-168.25%
ROE(3y)-139.15%
ROE(5y)-240.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 2601.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 11.8
Quick Ratio 11.8
Altman-Z 38.76
F-Score3
WACC9.99%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)909.1%
Cap/Sales(5y)2901.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
EPS Next Y17.65%
EPS Next 2Y20.19%
EPS Next 3Y66.8%
EPS Next 5Y64.54%
Revenue 1Y (TTM)10.41%
Revenue growth 3Y374.83%
Revenue growth 5Y78.65%
Sales Q2Q%1998.62%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-23.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year33.38%
EBIT Next 3Y78.66%
EBIT Next 5Y69.61%
FCF growth 1Y-106.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-61.9%
OCF growth 3YN/A
OCF growth 5YN/A